Virological response with fully active etravirine: pooled results from the DUET-1 and DUET-2 trials.

Abstract

The objective of this subanalysis of the Phase III DUET trials was to examine virological response to an etravirine-containing regimen in patients harbouring virus fully sensitive to etravirine. Full etravirine sensitivity was defined as fold change in 50% effective concentration (FC) ≤3 or weighted genotypic score ≤2. At Week 48 in the etravirine group, 74… (More)
DOI: 10.1258/ijsa.2010.010139

Topics

1 Figure or Table

Cite this paper

@article{Clumeck2010VirologicalRW, title={Virological response with fully active etravirine: pooled results from the DUET-1 and DUET-2 trials.}, author={Nicolas Clumeck and Pedro Cahn and J. A. Martinez Molina and A. Mills and Stefaan J B Nijs and Johan H Vingerhoets and Jim Witek}, journal={International journal of STD & AIDS}, year={2010}, volume={21 11}, pages={738-40} }